| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
17,694 |
15,954 |
$4.42M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,600 |
2,757 |
$486K |
| 99199 |
Unlisted special service, procedure or report |
4,434 |
4,041 |
$292K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,818 |
1,816 |
$274K |
| 80053 |
Comprehensive metabolic panel |
16,689 |
15,708 |
$253K |
| A9150 |
Non-prescription drugs |
2,273 |
1,185 |
$209K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,780 |
3,509 |
$189K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,302 |
8,156 |
$188K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,514 |
1,464 |
$169K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,264 |
2,961 |
$166K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,799 |
19,088 |
$165K |
| A9270 |
Non-covered item or service |
3,099 |
1,766 |
$161K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,984 |
2,761 |
$140K |
| 80061 |
Lipid panel |
7,792 |
7,756 |
$139K |
| J3490 |
Unclassified drugs |
3,446 |
2,390 |
$137K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
2,127 |
1,101 |
$137K |
| 36415 |
Collection of venous blood by venipuncture |
9,374 |
8,507 |
$119K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,536 |
1,427 |
$119K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,220 |
1,214 |
$119K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,895 |
2,878 |
$113K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,129 |
1,871 |
$108K |
| 76830 |
Ultrasound, transvaginal |
919 |
912 |
$90K |
| 97750 |
|
662 |
542 |
$83K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,406 |
1,367 |
$82K |
| 71046 |
Radiologic examination, chest; 2 views |
2,548 |
2,501 |
$77K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,792 |
1,758 |
$75K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,901 |
4,861 |
$72K |
| 76641 |
|
583 |
538 |
$70K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,014 |
2,630 |
$69K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
679 |
527 |
$68K |
| 97139 |
|
1,029 |
303 |
$68K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
533 |
489 |
$63K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,281 |
1,984 |
$61K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,406 |
2,279 |
$60K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,951 |
1,902 |
$57K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,341 |
5,001 |
$56K |
| 84439 |
|
4,063 |
4,027 |
$56K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
459 |
457 |
$55K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
867 |
838 |
$55K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,807 |
2,715 |
$55K |
| 0510 |
|
1,072 |
1,014 |
$54K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,199 |
1,198 |
$54K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,267 |
4,017 |
$48K |
| G0378 |
Hospital observation service, per hour |
989 |
901 |
$47K |
| 81001 |
|
9,635 |
9,124 |
$46K |
| 73030 |
|
1,094 |
1,076 |
$43K |
| Z7502 |
|
1,057 |
1,034 |
$39K |
| 87088 |
|
2,821 |
2,682 |
$33K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
235 |
213 |
$30K |
| 72100 |
|
631 |
628 |
$29K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
462 |
214 |
$28K |
| 83880 |
|
2,086 |
1,931 |
$26K |
| 73630 |
|
594 |
572 |
$24K |
| 87634 |
|
1,321 |
1,294 |
$24K |
| 71045 |
Radiologic examination, chest; single view |
2,892 |
2,724 |
$23K |
| 87081 |
|
985 |
975 |
$22K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
310 |
302 |
$21K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,595 |
1,452 |
$21K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
482 |
439 |
$21K |
| 80076 |
|
3,838 |
3,690 |
$19K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
672 |
641 |
$18K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,614 |
1,486 |
$17K |
| 0250 |
|
8,067 |
4,399 |
$17K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
123 |
120 |
$16K |
| J2704 |
Injection, propofol, 10 mg |
63 |
52 |
$16K |
| 87430 |
|
628 |
617 |
$15K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
306 |
275 |
$15K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
453 |
445 |
$14K |
| 81025 |
|
2,313 |
2,237 |
$14K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
454 |
446 |
$13K |
| 73562 |
|
322 |
315 |
$13K |
| 73130 |
|
316 |
308 |
$12K |
| 87186 |
|
1,586 |
1,502 |
$12K |
| 0760 |
|
227 |
214 |
$12K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
228 |
202 |
$12K |
| 0710 |
|
250 |
243 |
$11K |
| 82607 |
|
904 |
903 |
$11K |
| 87077 |
|
1,250 |
1,189 |
$11K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
219 |
214 |
$11K |
| 86140 |
|
1,699 |
1,657 |
$11K |
| 27096 |
|
21 |
12 |
$11K |
| 85610 |
|
3,408 |
3,142 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
153 |
152 |
$10K |
| 82728 |
|
509 |
499 |
$10K |
| 84484 |
|
2,813 |
2,484 |
$9K |
| 82746 |
|
369 |
369 |
$8K |
| 83540 |
|
891 |
878 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
106 |
94 |
$8K |
| 85018 |
|
2,096 |
2,085 |
$8K |
| 83690 |
|
3,364 |
3,188 |
$8K |
| 85730 |
|
2,432 |
2,340 |
$8K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
15 |
15 |
$7K |
| 81002 |
|
1,869 |
1,825 |
$7K |
| 84153 |
|
253 |
251 |
$7K |
| 84466 |
|
356 |
353 |
$6K |
| 84481 |
|
281 |
281 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
193 |
192 |
$6K |
| 73564 |
|
124 |
123 |
$6K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
221 |
217 |
$6K |
| 72040 |
|
141 |
140 |
$6K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
621 |
585 |
$6K |
| 99215 |
Prolong outpt/office vis |
107 |
98 |
$6K |
| 87070 |
|
504 |
495 |
$5K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
84 |
80 |
$5K |
| 85651 |
|
1,063 |
1,040 |
$5K |
| 0270 |
|
668 |
387 |
$5K |
| 73110 |
|
112 |
104 |
$5K |
| 85027 |
|
654 |
597 |
$5K |
| 83735 |
|
1,037 |
918 |
$4K |
| 86803 |
|
183 |
181 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
411 |
301 |
$3K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
51 |
48 |
$3K |
| 73502 |
|
54 |
54 |
$3K |
| 84403 |
|
65 |
64 |
$3K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
52 |
50 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
174 |
149 |
$3K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
12 |
12 |
$2K |
| 82043 |
|
252 |
252 |
$2K |
| 92551 |
|
82 |
82 |
$2K |
| 83605 |
|
855 |
795 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
185 |
148 |
$2K |
| 73610 |
|
41 |
38 |
$2K |
| 90715 |
|
41 |
38 |
$2K |
| 86710 |
|
72 |
70 |
$1K |
| 87040 |
|
406 |
371 |
$1K |
| 86780 |
|
124 |
121 |
$1K |
| 86038 |
|
92 |
91 |
$1K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
12 |
12 |
$1K |
| 96127 |
|
168 |
156 |
$1K |
| 73600 |
|
27 |
26 |
$1K |
| 96376 |
|
119 |
106 |
$837.15 |
| 82150 |
|
255 |
247 |
$799.63 |
| 85652 |
|
239 |
232 |
$763.41 |
| 86430 |
|
75 |
75 |
$721.59 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
241 |
189 |
$720.49 |
| 87340 |
|
38 |
38 |
$708.94 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$666.34 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
24 |
24 |
$640.78 |
| 94729 |
|
13 |
13 |
$610.35 |
| 94060 |
|
13 |
13 |
$605.86 |
| 93971 |
|
13 |
13 |
$587.39 |
| 80074 |
|
12 |
12 |
$579.26 |
| 94726 |
|
13 |
13 |
$542.36 |
| 82962 |
|
29 |
26 |
$520.88 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
12 |
12 |
$446.60 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
13 |
12 |
$436.13 |
| 77080 |
|
13 |
13 |
$416.76 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
204 |
204 |
$402.72 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
24 |
24 |
$360.38 |
| 99173 |
|
91 |
91 |
$332.86 |
| 84145 |
|
124 |
118 |
$329.20 |
| J2060 |
Injection, lorazepam, 2 mg |
103 |
89 |
$286.01 |
| 86039 |
|
29 |
29 |
$250.00 |
| 83655 |
|
25 |
25 |
$195.09 |
| 82550 |
|
27 |
26 |
$178.19 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
12 |
12 |
$172.82 |
| 86160 |
|
12 |
12 |
$159.24 |
| 82248 |
|
13 |
13 |
$95.42 |
| 84550 |
|
14 |
14 |
$84.93 |
| 85007 |
|
64 |
51 |
$73.48 |
| 72020 |
|
54 |
52 |
$44.18 |
| 76000 |
|
25 |
24 |
$41.28 |
| 84703 |
|
28 |
28 |
$15.87 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13 |
12 |
$9.19 |
| 0370 |
|
16 |
15 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
13 |
$0.00 |
| 0253 |
|
60 |
51 |
$0.00 |
| 0272 |
|
25 |
24 |
$0.00 |
| 0360 |
|
14 |
14 |
$0.00 |